MaryRose Reaston is the co-founder, CEO and chief science officer of Emerge Diagnostics, which focuses on better outcomes for musculoskeletal disorders via early resolution and enhanced treatment options for soft-tissue injuries.
Emerge Diagnostics was created to commercialize the electrodiagnostic functional assessment (EFA).
The trucking industry accounted for nearly 20 percent of all days-away-from-work cases in 2011. Correspondingly, trucking was among the seven occupations which had an incidence rate greater than 300 cases per 10,000 full-time workers and who had greater than 20,000 days-away-from-work cases. OSHA defines a Musculoskeletal Disorder (MSD) as an injury of the muscles, nerves, […]